Evolus, Inc.

NasdaqGM:EOLS Stok Raporu

Piyasa değeri: US$825.7m

Evolus Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

David Moatazedi

İcra Kurulu Başkanı

US$11.2m

Toplam tazminat

CEO maaş yüzdesi6.1%
CEO görev süresi6.5yrs
CEO sahipliğin/a
Yönetim ortalama görev süresi3yrs
Yönetim Kurulu ortalama görev süresi6.5yrs

Son yönetim güncellemeleri

Recent updates

Evolus, Inc. (NASDAQ:EOLS) Might Not Be As Mispriced As It Looks After Plunging 26%

Nov 13
Evolus, Inc. (NASDAQ:EOLS) Might Not Be As Mispriced As It Looks After Plunging 26%

Does Evolus (NASDAQ:EOLS) Have A Healthy Balance Sheet?

Oct 22
Does Evolus (NASDAQ:EOLS) Have A Healthy Balance Sheet?

Evolus Continues To Make Progress

Aug 02

Evolus, Inc. (NASDAQ:EOLS) Looks Just Right With A 32% Price Jump

Aug 02
Evolus, Inc. (NASDAQ:EOLS) Looks Just Right With A 32% Price Jump

Evolus (NASDAQ:EOLS) Is Making Moderate Use Of Debt

Jul 13
Evolus (NASDAQ:EOLS) Is Making Moderate Use Of Debt

Evolus: Chiseling Away At The Aesthetic Market

May 22

Analysts Are Updating Their Evolus, Inc. (NASDAQ:EOLS) Estimates After Its First-Quarter Results

May 10
Analysts Are Updating Their Evolus, Inc. (NASDAQ:EOLS) Estimates After Its First-Quarter Results

Evolus: Smooth Progress As Management Targets $700m Aesthetics Franchise Revenues By 2028

Mar 20

The Evolus, Inc. (NASDAQ:EOLS) Full-Year Results Are Out And Analysts Have Published New Forecasts

Mar 10
The Evolus, Inc. (NASDAQ:EOLS) Full-Year Results Are Out And Analysts Have Published New Forecasts

Evolus, Inc. (NASDAQ:EOLS) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Jan 18
Evolus, Inc. (NASDAQ:EOLS) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Evolus, Inc.'s (NASDAQ:EOLS) Shares Climb 27% But Its Business Is Yet to Catch Up

Jan 18
Evolus, Inc.'s (NASDAQ:EOLS) Shares Climb 27% But Its Business Is Yet to Catch Up

Would Evolus (NASDAQ:EOLS) Be Better Off With Less Debt?

Jun 16
Would Evolus (NASDAQ:EOLS) Be Better Off With Less Debt?

Does Evolus (NASDAQ:EOLS) Have A Healthy Balance Sheet?

Nov 06
Does Evolus (NASDAQ:EOLS) Have A Healthy Balance Sheet?

Evolus concludes certain royalty payments related to settlement of IP rights dispute

Sep 21

Evolus: Turning That Frown Upside Down

Sep 11

Evolus appoints Experian's exec as CFO

Aug 30

Is Evolus (NASDAQ:EOLS) Using Too Much Debt?

Aug 04
Is Evolus (NASDAQ:EOLS) Using Too Much Debt?

Evolus Q2 2022 Earnings Preview

Aug 01

Is Evolus (NASDAQ:EOLS) Using Debt Sensibly?

Mar 21
Is Evolus (NASDAQ:EOLS) Using Debt Sensibly?

CEO Tazminat Analizi

David Moatazedi'un ücretlendirmesi Evolus'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$55m

Jun 30 2024n/an/a

-US$53m

Mar 31 2024n/an/a

-US$60m

Dec 31 2023US$11mUS$688k

-US$62m

Sep 30 2023n/an/a

-US$63m

Jun 30 2023n/an/a

-US$66m

Mar 31 2023n/an/a

-US$72m

Dec 31 2022US$4mUS$597k

-US$74m

Sep 30 2022n/an/a

-US$79m

Jun 30 2022n/an/a

-US$79m

Mar 31 2022n/an/a

-US$71m

Dec 31 2021US$4mUS$572k

-US$47m

Sep 30 2021n/an/a

-US$139m

Jun 30 2021n/an/a

-US$131m

Mar 31 2021n/an/a

-US$137m

Dec 31 2020US$3mUS$527k

-US$163m

Sep 30 2020n/an/a

-US$67m

Jun 30 2020n/an/a

-US$82m

Mar 31 2020n/an/a

-US$99m

Dec 31 2019US$2mUS$550k

-US$90m

Sep 30 2019n/an/a

-US$88m

Jun 30 2019n/an/a

-US$73m

Mar 31 2019n/an/a

-US$52m

Dec 31 2018US$6mUS$362k

-US$47m

Tazminat ve Piyasa: David 'nin toplam tazminatı ($USD 11.24M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 3.20M ).

Tazminat ve Kazançlar: David şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

David Moatazedi (46 yo)

6.5yrs

Görev süresi

US$11,240,447

Tazminat

Mr. David Moatazedi is Independent Director at Biomerica Inc. from December 07, 2022. He has been the President, Chief Executive Officer and Director of Evolus, Inc. since joining it on May 6, 2018. Mr. Mo...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
David Moatazedi
President6.5yrsUS$11.24mVeri yok
Sandra Beaver
Chief Financial Officer2.2yrsUS$2.46m0.052%
$ 427.6k
Rui Avelar
Chief Medical Officer and Head of Research & Development10.8yrsUS$2.93m0.31%
$ 2.6m
Nareg Sagherian
Head of Global Investor Relations & Corporate Communicationsless than a yearVeri yokVeri yok
Jeffrey Plumer
General Counselno dataVeri yokVeri yok
Kurt Knab
Vice President of Sales6.1yrsVeri yokVeri yok
Tomoko Yamagishi-Dressler
Chief Marketing Officer1.3yrsVeri yok0.016%
$ 133.1k
Jessica Novak
Senior Vice President of Human Resources3yrsVeri yokVeri yok

3.0yrs

Ortalama Görev Süresi

46yo

Ortalama Yaş

Deneyimli Yönetim: EOLS 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
David Moatazedi
President6.5yrsUS$11.24mVeri yok
David Gill
Independent Director6.8yrsUS$256.03k0.043%
$ 358.6k
Simone Blank
Director6.8yrsUS$235.03k0.86%
$ 7.1m
Albert White
Independent Directorless than a yearVeri yokVeri yok
Vikram Malik
Chairman of the Board6.8yrsUS$271.03k0.37%
$ 3.1m
Karah Parschauer
Independent Director5.3yrsUS$249.03k0.049%
$ 407.4k
Brady Stewart
Independent Director2.8yrsUS$222.03k0.071%
$ 584.2k

6.5yrs

Ortalama Görev Süresi

54yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: EOLS 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.5 yıldır).